Henri M.H. Spronk
机构: Associate Professor Biochemistry, Maastricht University
每年引用次数
引用次数
引用: 13,987
H-指数: 59
I10-指数 : 167
出版物: 424
Activated protein C therapy prevents against complex atherosclerosis progression in mice with genetically impaired anticoagulant response
J Borissoff , STBG Loubele , S Heeneman , P Leenders
JOURNAL OF THROMBOSIS AND HAEMOSTASIS 9 234 -234
2011
EXPOSURE TO COMBUSTION DERIVED NANOPARTICLES DOES NOT ALTER TISSUE FACTOR MEDIATED THROMBIN GENERATION IN HEALTHY YOUNG ADULTS
E Kilinç , HMH Spronk , J Serroyen , FR Cassee
Effects of Air Pollution on Haemostasis and Atherosclerosis 115 -115
2011
Delayed and decreased thrombin generation is associated with stroke in the elderly: results from the prosper study associate
R Loeffen , K Winckers , I Ford , JW Jukema
Journal of Thrombosis and Haemostasis 11 228 -228
2013
Coagulation factors and the protein C system as determinants of thrombin generation in a normal population
AWJH Dielis , E Castoldi , HMH Spronk , R Van Oerle
Journal of Thrombosis and Haemostasis 6 ( 1) 125 -131
282
2008
Sustained inflammation, coagulation activation and elevated endothelin-1 levels without macrovascular dysfunction at 3 months after COVID-19
LH Willems , M Nagy , H Ten Cate , HMH Spronk
Thrombosis research 209 106 -114
61
2022
Antithrombotic therapy: prevention and treatment of atherosclerosis and atherothrombosis
RH Olie , PEJ Van Der Meijden , HMH Spronk , H Ten Cate
Prevention and Treatment of Atherosclerosis: Improving State-of-the-Art Management and Search for Novel Targets 103 -130
19
2020
Calibrated automated thrombogram II: removing barriers for thrombin generation measurements
PLA Giesen , AJW Gulpen , R van Oerle , H Ten Cate
Thrombosis Journal 19 ( 1) 60 -60
11
2021
Liver cirrhosis is associated with hypercoagulability, decreased clot strength and normal fibrinolysis
MC Kleinegris , CAM Habets , AJP Van De Sande , YMC Henskens
JOURNAL OF THROMBOSIS AND HAEMOSTASIS 11 49 -50
8
2013
Discovery of four plasmatic biomarkers potentially predicting cardiovascular outcome in peripheral artery disease
BMM Kremers , JN Posma , S Heitmeier , J Glunz
Scientific Reports 12 ( 1) 18388 -18388
6
2022
Diabetes-versus smoking-related thrombo-inflammation in peripheral artery disease
T Alnima , RI Meijer , HMH Spronk , M Warlé
Cardiovascular Diabetology 22 ( 1) 257 -257
4
2023
Translational insights into mechanisms underlying residual venous obstruction and the role of factor XI, P-selectin and GPVI in recurrent venous thromboembolism
AFJ Iding , BMM Kremers , M Nagy , A Pallares Robles
Thrombosis Research 221 58 -64
4
2023
Enhanced endogenous thrombin potential is associated with the severity of coronary atherosclerosis
J Borissoff , IAPG Joosen , MO Versteylen , HMH Spronk
JOURNAL OF THROMBOSIS AND HAEMOSTASIS 9 746 -746
3
2011
Inadequate response to antiplatelet therapy in patients with peripheral artery disease: a prospective cohort study
BMM Kremers , JHC Daemen , H Ten Cate , HMH Spronk
Thrombosis Journal 21 ( 1) 5 -5
2
2023
Localisation of coagulation proteins within the arterial vessel wall in relation to progression of atherosclerosis
P Kassak , S Heeneman , M Verluyten , MJAP Daemen
JOURNAL OF VASCULAR RESEARCH 42 84 -84
2
2005
Plasma protein signatures for high on-treatment platelet reactivity to aspirin and clopidogrel in peripheral artery disease
Gaukhar Baidildinova , A Pallares Robles , Vincent ten Cate , Bram MM Kremers
Thrombosis Research 230 105 -118
1
2023
Bepaling van trombinegeneratie in plasma: een zinvolle stollingstest?
HMH Spronk , AJ ten Cate-Hoek , AW Dielis , K Hamulyák
Ned Tijdschr Hematol 6 22 -7
1
2009
OPEN ACCESS EDITED BY
Bas De Laat , Ton Lisman , Paul Billoir , Mark MG Mulder
Advances in thrombin generation 69 -69
2023
Atrial fibrillation and age synergistically increase clotting potential and promote atrial structural remodeling in goats
E D’Alessandro , B Scaf , V Sobota , A Van Hunnik
Europace 24 ( Supplement_1) euac053. 618 -euac053. 618
2022
Sustained endothelial, coagulation and inflammatory cytokine activation without macrovascular dysfunction at 3 months after COVID-19: a reflection on SARS-CoV-2 induced thrombo-inflammation
LH Willems , M Nagy , H Ten Cate , HMH Spronk
European Heart Journal 42 ( Supplement_1) ehab724. 2518 -ehab724. 2518
2021
Effects of the PAR-1 receptor antagonist vorapaxar on platelet activation and coagulation biomarkers in patients with stable coronary artery disease
RH Olie , PEJ Van Der Meijden , HMH Spronk , R Van Oerle
EUROPEAN HEART JOURNAL 39 50 -50
2018